BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+29.56%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.89B
AUM Growth
+$2.89B
Cap. Flow
-$160M
Cap. Flow %
-5.52%
Top 10 Hldgs %
55.7%
Holding
79
New
14
Increased
13
Reduced
3
Closed
4

Top Buys

1
ITOS icon
iTeos Therapeutics
ITOS
$107M
2
PMVP icon
PMV Pharmaceuticals
PMVP
$80.5M
3
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$54.2M
4
RLAY icon
Relay Therapeutics
RLAY
$53.3M
5
NRIX icon
Nurix Therapeutics
NRIX
$47.3M

Top Sells

1
LABD icon
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$403M
2
IMMU
Immunomedics Inc
IMMU
$179M
3
MRNS
Marinus Pharmaceuticals, Inc
MRNS
$92.5M
4
PRNB
Principia Biopharma Inc. Common Stock
PRNB
$36.3M
5
TRIL
Trillium Therapeutics Inc.
TRIL
$33M

Sector Composition

1 Healthcare 85.05%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IMMU
1
DELISTED
Immunomedics Inc
IMMU
$383M 13.22% 4,500,000 -2,106,000 -32% -$179M
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$319M 11.03% 1,114,188 +189,188 +20% +$54.2M
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$293M 10.13% 1,765,560 – –
RVMD icon
4
Revolution Medicines
RVMD
$7.1B
$115M 3.98% 3,309,264 +350,000 +12% +$12.2M
ITOS icon
5
iTeos Therapeutics
ITOS
$107M 3.7% +4,345,016 New +$107M
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
$99M 3.42% 2,075,905 – –
PMVP icon
7
PMV Pharmaceuticals
PMVP
$74.2M
$80.5M 2.78% +2,268,236 New +$80.5M
SGEN
8
DELISTED
Seagen Inc. Common Stock
SGEN
$78.3M 2.71% 400,000 – –
ODT
9
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$69.9M 2.42% 5,207,086 +1,843,709 +55% +$24.8M
SAGE
10
DELISTED
Sage Therapeutics
SAGE
$66.9M 2.31% 1,094,000 – –
BDTX icon
11
Black Diamond Therapeutics
BDTX
$157M
$60.9M 2.1% 2,014,858 – –
ALLK
12
DELISTED
Allakos
ALLK
$55M 1.9% 675,000 – –
RLAY icon
13
Relay Therapeutics
RLAY
$619M
$53.3M 1.84% +1,251,959 New +$53.3M
ICPT
14
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$48.8M 1.68% 1,176,000 +1,050,000 +833% +$43.5M
NRIX icon
15
Nurix Therapeutics
NRIX
$714M
$47.3M 1.63% +1,354,392 New +$47.3M
ARGX icon
16
argenx
ARGX
$43.6B
$44.9M 1.55% 170,926 – –
CGEN icon
17
Compugen
CGEN
$132M
$38.7M 1.34% 2,383,673 – –
ESPR icon
18
Esperion Therapeutics
ESPR
$448M
$36.2M 1.25% 975,000 – –
RCUS icon
19
Arcus Biosciences
RCUS
$1.13B
$35.7M 1.23% 2,084,883 – –
SNDX icon
20
Syndax Pharmaceuticals
SNDX
$1.41B
$33.8M 1.17% 2,287,782 – –
RCKT icon
21
Rocket Pharmaceuticals
RCKT
$354M
$33.5M 1.16% 1,466,051 – –
FOLD icon
22
Amicus Therapeutics
FOLD
$2.34B
$32.8M 1.13% 2,325,000 – –
KURA icon
23
Kura Oncology
KURA
$686M
$32.2M 1.11% 1,050,289 +205,500 +24% +$6.3M
GOSS icon
24
Gossamer Bio
GOSS
$562M
$31.8M 1.1% 2,562,358 – –
RNA icon
25
Avidity Biosciences
RNA
$5.99B
$31.6M 1.09% 1,121,327 – –
1
2 3 4